Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 23689487)

2.

Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy.

Goldin GH, Sheets NC, Meyer AM, Kuo TM, Wu Y, Stürmer T, Godley PA, Carpenter WR, Chen RC.

JAMA Intern Med. 2013 Jun 24;173(12):1136-43. doi: 10.1001/jamainternmed.2013.1020.

PMID:
23689844
3.
4.

Intensity modulated radiation therapy replaces 3-dimensional conformal radiotherapy as prostate cancer treatment.

Elliott SP, Adejoro OO, Konety BR, Jarosek SL, Dusenbery KE, Virnig BA.

J Urol. 2012 Apr;187(4):1253-8. doi: 10.1016/j.juro.2011.11.088. Epub 2012 Feb 14.

PMID:
22335868
5.

Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.

Hummel S, Simpson EL, Hemingway P, Stevenson MD, Rees A.

Health Technol Assess. 2010 Oct;14(47):1-108, iii-iv. doi: 10.3310/hta14470. Review.

6.

Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?

Bossi A, De Meerleer G, Ost P.

Eur Urol. 2011 Dec;60(6):1149-50; discussion 1150-1. doi: 10.1016/j.eururo.2011.08.056. Epub 2011 Sep 7. No abstract available.

PMID:
21920662
7.

Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer.

Prada PJ, Mendez L, Fernández J, González H, Jiménez I, Arrojo E.

Radiat Oncol. 2012 Mar 7;7:31. doi: 10.1186/1748-717X-7-31.

8.

Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer.

Tao Y, Lefkopoulos D, Ibrahima D, Bridier A, Polizzi Mdel P, Wibault P, De Crevoisier R, Arriagada R, Bourhis J.

Acta Oncol. 2008;47(3):442-50. Epub 2007 Sep 28.

PMID:
17906985
9.

Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.

Lips I, Dehnad H, Kruger AB, van Moorselaar J, van der Heide U, Battermann J, van Vulpen M.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):656-61. Epub 2007 May 23.

PMID:
17512127
10.

Intermediate- and high-risk prostate cancer: a plea for high-dose, high-precision intensity-modulated radiotherapy with a modulated duration of androgen deprivation therapy.

Bolla M.

Eur Urol. 2011 Dec;60(6):1140-1. doi: 10.1016/j.eururo.2011.09.006. Epub 2011 Sep 15. No abstract available.

PMID:
21944436
11.

Intensity-modulated radiotherapy in the treatment of prostate cancer.

Bauman G, Rumble RB, Chen J, Loblaw A, Warde P; Members of the IMRT Indications Expert Panel.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):461-73. doi: 10.1016/j.clon.2012.05.002. Epub 2012 Jun 4. Review.

PMID:
22673744
12.

Editorial comment on: Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Yossepowitch O.

Eur Urol. 2009 Oct;56(4):676-7. doi: 10.1016/j.eururo.2009.05.043. Epub 2009 May 29. No abstract available.

PMID:
19501457
13.

Editorial comment on: Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Da Pozzo LF.

Eur Urol. 2009 Oct;56(4):675-6. doi: 10.1016/j.eururo.2009.05.042. Epub 2009 May 29. No abstract available.

PMID:
19501455
14.

Late toxicity after conformal and intensity-modulated radiation therapy for prostate cancer: impact of previous surgery for benign prostatic hyperplasia.

Odrazka K, Dolezel M, Vanasek J, Vaculikova M, Zouhar M, Sefrova J, Paluska P, Vosmik M, Kohlova T, Kolarova I, Navratil P, Brodak M, Prosvic P, Hoffmann P.

Int J Urol. 2010 Sep;17(9):784-90. doi: 10.1111/j.1442-2042.2010.02592.x. Epub 2010 Jul 6.

PMID:
20604816
15.

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.

J Urol. 2001 Sep;166(3):876-81. Erratum in: J Urol 2001 Nov;166(5):1839.

PMID:
11490237
16.

Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial.

Massaccesi M, Cilla S, Deodato F, Digesù C, Macchia G, Caravatta L, Ippolito E, Picardi V, Ferro M, Mignogna S, Mattiucci GC, Valentini V, Piermattei A, Morganti AG.

Anticancer Res. 2013 Jun;33(6):2785-9.

PMID:
23749942
17.

Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity.

Pollack A, Zagars GK, Rosen II.

Semin Oncol. 1999 Apr;26(2):150-61. Review.

PMID:
10597726
18.

[Review on the effectiveness of prostate cancer brachytherapy].

Inciūra A, Jarusevicus L, Vaiciūnas K, Juozaityte E.

Medicina (Kaunas). 2009;45(8):660-71. Review. Lithuanian.

19.

Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.

Yong JH, Beca J, McGowan T, Bremner KE, Warde P, Hoch JS.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):521-31. doi: 10.1016/j.clon.2012.05.004. Epub 2012 Jun 15.

PMID:
22705100
20.

[Salvage radiotherapy for pT3 prostate cancer with PSA failure after radical prostatectomy].

Wakita T, Hayashi N, Fuwa N.

Hinyokika Kiyo. 2005 Sep;51(9):575-80. Review. Japanese.

PMID:
16229369
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk